Author`s Reply.
作者信息
Güler Ekrem, Babur Güler Gamze, Demir Gültekin Günhan, Hatipoğlu Suzan
机构信息
Department of Cardiology, Faculty of Medicine, Medipol University, İstanbul-Turkey.
Department of Cardiology, Ersoy Hospital, İstanbul-Turkey.
出版信息
Anatol J Cardiol. 2016 Mar;16(3):220-1.
Abstract
摘要
相似文献
1
Author`s Reply.作者回复。
Anatol J Cardiol. 2016 Mar;16(3):220-1.
2
Author`s Reply.作者回复。
Anadolu Kardiyol Derg. 2014 May;14(3):309.
3
Author`s Reply.
Anatol J Cardiol. 2016 Mar;16(3):227-8.
4
Author`s Reply.作者回复。
Anatol J Cardiol. 2016 Mar;16(3):226.
5
Author`s Reply.
Anatol J Cardiol. 2016 Mar;16(3):225.
6
Author`s Reply.作者回复。
Anatol J Cardiol. 2016 Mar;16(3):223-4.
7
Author`s reply.作者回复。
Anadolu Kardiyol Derg. 2014 May;14(3):304.
8
Author`s Reply.作者回复。
Anatol J Cardiol. 2016 Mar;16(3):222-3.
9
Author`s Reply.作者回复。
Anatol J Cardiol. 2016 Mar;16(3):219.
10
Author`s Reply.作者回复。
Anatol J Cardiol. 2016 Feb;16(2):142-3.
本文引用的文献
1
A review of the fixed dose use of new oral anticoagulants in obese patients: Is it really enough?肥胖患者新型口服抗凝剂固定剂量使用的综述：真的足够吗？
Anatol J Cardiol. 2015;15(12):1020-9. doi: 10.5152/AnatolJCardiol.2015.6532.
2
Rivaroxaban concentration in patients with deep vein thrombosis who reported thrombus progression or minor hemorrhagic complications: first Polish experience.
Pol Arch Med Wewn. 2014;124(10):553-5. doi: 10.20452/pamw.2470. Epub 2014 Oct 10.
3
Measuring Oral Direct Inhibitors (ODIs) of thrombin and factor Xa: A recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.凝血酶和Xa因子口服直接抑制剂的检测：国际血栓与止血学会科学与标准化委员会抗凝控制小组委员会的建议
J Thromb Haemost. 2013 Jan 24. doi: 10.1111/jth.12149.
4
Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation – the J-ROCKET AF study –.利伐沙班与华法林在日本非瓣膜性心房颤动患者中的比较——J-ROCKET AF 研究。
Circ J. 2012;76(9):2104-11. doi: 10.1253/circj.cj-12-0454. Epub 2012 Jun 5.
Zotero 插件